Alnylam Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $24M | 162k | 149.45 |
| 2023-12-31 | $22M | 113k | 191.43 |
| 2023-09-30 | $13M | 75k | 177.10 |
| 2023-06-30 | $14M | 74k | 189.92 |
| 2023-03-31 | $8.4M | 42k | 200.32 |
| 2022-12-31 | $12M | 49k | 237.65 |
| 2022-09-30 | $9.1M | 46k | 200.21 |
| 2022-06-30 | $3.7M | 25k | 145.93 |
| 2022-03-31 | $4.6M | 28k | 163.43 |
| 2021-12-31 | $15M | 90k | 169.57 |
| 2021-09-30 | $4.2M | 22k | 188.83 |
| 2021-06-30 | $3.0M | 19k | 160.00 |
| 2021-03-31 | $3.0M | 21k | 141.17 |
| 2020-12-31 | $2.8M | 21k | 130.43 |
| 2020-09-30 | $3.2M | 22k | 145.60 |
| 2020-06-30 | $3.6M | 24k | 148.13 |
| 2020-03-31 | $4.6M | 42k | 108.83 |
| 2019-12-31 | $3.8M | 33k | 114.67 |
| 2019-09-30 | $5.7M | 71k | 80.41 |
| 2019-06-30 | $2.1M | 28k | 72.54 |
| 2019-03-31 | $4.5M | 49k | 93.25 |
| 2018-12-31 | $10M | 139k | 72.75 |
| 2018-09-30 | $8.2M | 93k | 87.85 |
| 2018-06-30 | $5.3M | 54k | 98.91 |
| 2018-03-31 | $12M | 98k | 119.42 |
| 2017-12-31 | $10M | 80k | 126.97 |
| 2017-09-30 | $19M | 160k | 117.49 |
| 2017-06-30 | $15M | 192k | 79.76 |
| 2017-03-31 | $3.2M | 62k | 51.26 |
| 2016-12-31 | $4.2M | 112k | 37.44 |
| 2016-09-30 | $4.3M | 64k | 67.78 |
| 2016-06-30 | $5.3M | 96k | 55.51 |
| 2016-03-31 | $2.6M | 41k | 62.76 |
| 2015-12-31 | $11M | 114k | 94.14 |
| 2015-09-30 | $8.7M | 108k | 80.35 |
| 2015-03-31 | $2.5M | 24k | 102.04 |